Use of a parathyroid hormone peptide (PTH 1-34)-enriched fibrin hydrogel for the treatment of subchondral cystic lesions in 15 horses by Jackson, Michelle Amanda et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Use of a parathyroid hormone peptide (PTH 1-34)-enriched fibrin hydrogel
for the treatment of subchondral cystic lesions in 15 horses
Jackson, M A; Ohlerth, S; Kummer, M; Bettschart-Wolfensberger, R; Watson, J; Manera, C L; von
Rechenberg, B; Auer, J A; Fürst, A
Abstract: Various treatment methods have been used for the management of subchondral cystic lesions
(SCLs) in horses. Filling the defect with parathyroid hormone fragment peptide 1-34 (PTH1-34) in a
fibrin matrix represents a relatively new approach that requires further investigation. For this reason
fifteen horses with clinical and radiographic evidence of a total of sixteen SCLs (one horse bilaterally
affected) were treated surgically with debridement of the cystic contents and injection of PTH1-34 in a
fibrin hydrogel into the cyst cavity. Objectives of the study were to determine the clinical and radiographic
outcome of SCLs treated locally with PTH1-34 and to identify factors that may predict outcome. Clinical
and radiographic follow-up examinations were carried out at two, four, six and 12 months postoperatively
and a telephone inquiry was carried out five to seven years later. The mean age of the horses was 4.9
years. Six SCLs were in the medial condyle of the femur, three in the distal metacarpus, three in the
proximal sesamoid bone, two in the first phalanx, one in the patella and one in the calcaneus. Treatment
was considered successful in 11 of the 15 cases (73%) because the horses were sound and returned to
full work. In the remaining patients, there was improvement in one and no change in three others after
treatment. Based on the outcome of this study, PTH1-34 in a fibrin matrix administered directly into the
cyst after surgical debridement appears to be a promising treatment option for treating SCLs at various
anatomic sites in horses
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-71840
Published Version
Originally published at:
Jackson, M A; Ohlerth, S; Kummer, M; Bettschart-Wolfensberger, R; Watson, J; Manera, C L; von
Rechenberg, B; Auer, J A; Fürst, A (2012). Use of a parathyroid hormone peptide (PTH 1-34)-enriched
fibrin hydrogel for the treatment of subchondral cystic lesions in 15 horses. Pferdeheilkunde, 28(6):642-
649.
Pferdeheilkunde 28 1
Pferdeheilkunde 28 (2012) 6 (November/Dezember)
Use of a parathyroid hormone peptide (PTH1-34)-enriched
fibrin hydrogel for the treatment of subchondral cystic
lesions in 15 horses
Michelle A. Jackson1, Stephanie Ohlerth2, Martin Kummer1, Regula Bettschart3, John Watson4, Celine L. Manera1, Brigitte von Rechen-
berg5, Jörg Auer1 and Anton Fürst1
Equine Department1, Section of Diagnostic Imaging2, Section of Anaesthesia3, Vetsuisse Faculty, University of Zurich, Switzerland, Kuros Biosurgery AG, Zurich,
Switzerland4 and Musculoskeletal Research Unit, Equine Department, Vetsuisse Faculty, University of Zurich, Switzerland5
Summary
Various treatment methods have been used for the management of subchondral cystic lesions (SCLs) in horses. Filling the defect with para-
thyroid hormone fragment peptide 1-34 (PTH1-34) in a fibrin matrix represents a relatively new approach that requires further investigation.
For this reason fifteen horses with clinical and radiographic evidence of a total of sixteen SCLs (one horse bilaterally affected) were treated
surgically with debridement of the cystic contents and injection of PTH1-34 in a fibrin hydrogel into the cyst cavity. Objectives of the study
were to determine the clinical and radiographic outcome of SCLs treated locally with PTH1-34 and to identify factors that may predict out-
come. Clinical and radiographic follow-up examinations were carried out at two, four, six and 12 months postoperatively and a telepho-
ne inquiry was carried out five to seven years later. The mean age of the horses was 4.9 years. Six SCLs were in the medial condyle of the
femur, three in the distal metacarpus, three in the proximal sesamoid bone, two in the first phalanx, one in the patella and one in the cal-
caneus. Treatment was considered successful in 11 of the 15 cases (73%) because the horses were sound and returned to full work. In the
remaining patients, there was improvement in one and no change in three others after treatment. Based on the outcome of this study, 
PTH1-34 in a fibrin matrix administered directly into the cyst after surgical debridement appears to be a promising treatment option for tre-
ating SCLs at various anatomic sites in horses.
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Der Einsatz von Fibrin Hydrogel angereichert mit Parathyroidhormon Peptid (PTH1-34) für die Behandlung von subchondralen
Knochenzysten in 15 Pferde
Verschiedene Behandlungsmethoden werden für die Therapie von subchondralen Knochenzysten beim Pferd (SKZ) mit unterschiedlichem
Erfolg eingesetzt. In dieser Arbeit werden fünfzehn Pferde mit insgesamt 16 SKZ beschrieben, die mit einem Parathyroidhormon Peptid Frag-
ment 1-34 (PTH1-34) angereichert in einer Fibrin-Hydrogel behandelt wurden. Der Zysteninhalt wurde kürettiert, gespült, getrocknet und
anschliessend mit PTH1-34 in einem Fibrin-Hydrogel angereichert, gefüllt. Ziel der prospektiven Studie war es, den klinischen und radiolo-
gischen Verlauf der SKZ nach der Behandlung mit PTH1-34 angereichert im Fibrin-Hydrogel nach 2, 4, 6, 12 und mehr Monaten zu
beschreiben. Zudem wurden wichtige Faktoren identifiziert, die für die Prognose von SKZs von Bedeutung sind. Das durchschnittliche Alter
der Pferde betrug 4.9 Jahre. Sechs SKZs waren im medialen Femurkondylus, drei im distalen Metakarpus, zwei im lateralen und eine im
medialen Gleichbein, eine im proximalen und eine im distalen Fesselbein, eine in der Patella und eine im Kalkaneus. Elf von fünfzehn Pfer-
de (73%) konnten erfolgreich behandelt werden und in ihrer ursprünglichen Aktivität eingesetzt werden. Von den restlichen vier Patienten
zeigte ein Pferd eine Besserung der Lahmheit, blieb aber leichtgradig lahm, während bei den übrigen drei Pferden die Lahmheit unverän-
dert blieb. Neben der klinischen Heilung, zeigten viele Pferde auch eine vollständige radiologische Heilung. Die direkte Applikation von
PTH1-34 in einer Fibrinmatrix in die chirurgisch kürettierte Zystenhöhle scheint aufgrund dieser Resultate eine aussichtsvolle Therapiemög-
lichkeit von SKZ an verschiedenen anatomischen Stellen beim Pferd zu sein.
Schlüsselwörter: Pferd / subchondrale Knochenzysten (SKZ) / chirurgische Kürettage / Parathyroidhormone Peptid (PTH1-34) / Fibrin Hydro-
gel / Orthopädie
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Introduction
Subchondral cystic lesions (SCLs) are defined as radiolucent
areas of bone and they usually contain fibrous connective tis-
sue and serous synovial-like fluid. Depending on their stage
of development, SCLs may be well demarcated from the sur-
rounding tissue by a sclerotic rim (Fürst et al. 2007). In hor-
ses, SCLs occur most commonly in the distal femur, followed
by the phalanges (Sherlock und Mair 2011) including the
distal and proximal sesamoid bones, carpal bones, third
metacarpal and metatarsal bones, tibia, radius and talus (von
Rechenberg et al. 1998). The cysts are often found beneath
the weight-bearing surface of the joint and most communica-
te with the joint (McIlwraith 1982). Proposed mechanisms for
development of SCLs include osteochondrosis (Trotter 1981,
McIlwraith 1982), articular trauma (Kold et al. 1986, Ray et
al. 1996, Kümmerle et al. 2008, Hendrix et al. 2010), infec-
tion (Garcia-Lopez und Kirker-Head 2004) and osteolytic acti-
vity with an increase in the concentrations of inflammatory
mediators such as prostaglandin E2 (PGE2) and interleukin-1
(IL-1) and -6 (IL-6) (von Rechenberg et al. 2001). Subchon-
dral cystic lesions can be treated conservatively with stall rest,
controlled exercise and systemic or intra-articular medications
(Wallis et al. 2008), which include hyaluronan, corticostero-
ids, polysulphated glycosaminoglycans and benzopyrones
(Jackson et al. 2008). Methylprednisolone acetate has been
used successfully for the treatment of unicameral bone cysts
in humans (Scaglietti et al. 1982), and corticosteroids have
been investigated for treatment of SCLs in horses (Vandekey-
bus et al. 1999). In a recent study, injection of corticosteroids
into the fibrous tissue lining of SCLs in the medial femoral
condyle with the aid of an arthroscope had a success rate of
67%, regardless of the age of the horse (Wallis et al. 2008).
When conservative treatment fails and the lameness persists,
surgical curettage of the cyst is recommended (Bertone and
McIlwraith 1986, Kold et al. 1986, Jackson et al. 2000, Sto-
ry and Bramlage 2004, Smith et al. 2005). Surgical manage-
ment includes debridement of the cyst, followed in some
cases by filling of the lesion with cancellous bone grafts (Jak-
kson et al. 2000), chondrocytes and insulin-like growth fac-
tor (IGF I) (Nixon 2002), tricalcium phosphate granules (Fürst
et al. 1997), mesenchymal stem cells (Kraus und Kirker-Head
2006), or multiple osteochondral autografts in the form of a
mosaic plasty (Bodo et al. 2004, Janicek et al. 2010). The
results of those treatments vary and the reported success rates
range from 64 to 82% in young horses (White et al. 1986,
Howard et al. 1995). In older horses with an SCL in the medi-
al femoral condyle, the prognosis after surgical debridement
is worse than in younger horses (Smith et al. 2005). 
Parathyroid hormone (PTH) is a peptide hormone secreted by
the parathyroid gland and composed of 84 amino acids. The
main known function of this hormone is to increase serum
concentrations of calcium. When PTH is present in low con-
centrations, it stimulates new bone formation in the endocor-
tical region (Dempster et al. 1993, Oxlund et al. 1993). The
exact mechanism is not clear, but is thought to be the stimula-
tion of osteoblast proliferation (Rubin und Bilezikian 2003). In
previous experiments, locally applied PTH1-34 cross-linked to a
hydrogel in a fibrin base induced and enhanced localized new
bone formation (Kemper 2003). The use of PTH1-34 in a fibrin
hydrogel to treat an SCL in the proximal phalanx of a warm-
blood filly led to complete healing without complications (Fürst
et al. 2007). Two horses with a type Ia fracture of the proximal
phalanx and concurrent SCL were treated with internal fixation
using lag screws and curettage of the cyst via a transcortical
approach, followed by filling of the cavity with PTH1-34 in a
fibrin hydrogel (Kümmerle et al. 2008). Both returned to their
previous level of activity (Kümmerle et al. 2008).
The purpose of this study was to describe the treatment of a
series of SCLs at different anatomic sites using PTH1-34 in a
fibrin matrix and to investigate factors that may affect the out-
come. 
Material and methods
Case selection
Horses referred to the Equine Hospital, University of Zurich,
Switzerland, from December 2003 to May 2005 because of
lameness attributable to an SCL were included in the study.
Only horses that had no history of surgical treatment before
referral and had follow-up examinations for a minimum of 12
months postoperatively were included. The breed, age and sex
of the horse, results of clinical, radiographic and orthopaedic
examinations, which included duration and degree of lame-
ness (0-5 scale, Ross und Dyson 2011), palpation of the affec-
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ted limb, flexion tests and nerve blocks, and the surgical tech-
nique and results of follow-up examinations were recorded.
Radiographic assessment
A minimum of two views of the affected joint and the corre-
sponding contralateral joint were taken at the time of presen-
tation, and two views were obtained immediately after surge-
ry and two, four, six and 12 months postoperatively. All radio-
graphic images were reviewed by the same radiologist (S.O.).
The number, density and approximate size of the cyst relative
to the limb were evaluated on the radiographs. The density of
the cyst relative to the density of the normal surrounding bone
was determined subjectively using the following scoring
system: low (0-30% of the density of the surrounding bone),
mild (31-60% of the density of the surrounding bone), mode-
rate (61-90% of the density of the surrounding bone) and
high (density similar to that of the surrounding bone, >90%).
The approximate size of the cyst relative to the bone was
determined subjectively and the size of cysts was compared in
a series of related radiographs (before and after surgery and
at the different follow up times).
Surgical technique and aftercare
In six cases, the SCLs were debrided via an extraarticular
transosseous approach. A Siremobil Iso-C three-dimensional
fluoroscope (Siemens, Medical Solutions, Henkestrasse 127,
81052 Erlangen, Germany) was used to visualise the cysts
and monitor the direction of the instruments. First, a 3.2-mm
hole was drilled into the cyst, which was then enlarged to 4.5
or 5.5 mm. A decrease in pressure on the drill was felt by the
surgeon upon penetration of the cyst, which was confirmed by
fluoroscopy. Straight and angled arthroscopic curettes were
then used to remove as much of the contents and lining of the
cysts as possible. Lavage with sterile lactated Ringer’s solution
was carried out to remove all remnants of the contents and
lining of the cystic cavity. Finally, the two syringes of parathy-
roid fragment peptide 1-34 (PTH1-34) (Kuros Biosurgery AG,
Zurich, Switzerland) in fibrinogen and thrombin were concur-
rently mixed and injected via the drill hole into the surgically
prepared cystic cavity using an 18gauge needle. Clotting of
the hydrogel took place within 1 to 3 minutes and was verifi-
ed by gently tapping the material with a blunt metallic arthro-
scopic probe through the drill hole.
The remaining ten SCLs were debrided arthroscopically under
continuous irrigation with lactated Ringer’s solution. After
localization of the small opening to the joint (Fig.1a), each
SCL was curetted under arthroscopic control until all fibrous,
cartilaginous and necrotic bone tissue and the lining of the
cavity were removed (Fig.1b). Irrigation was then disconti-
nued and joint expansion was maintained using gas insuffla-
tion with carbon dioxide at a pressure of 60-80 mmHg. All
fluid including blood was removed. Finally, PTH 1-34 in fibrin
was injected as described above (Fig.1c). 
Postoperative care included four weeks of stall rest followed by
turnout in a small 5-6 x 5-6 meter paddock for four weeks.
Access to pasture was not allowed during this time. Hand wal-
king was advised for the following 2 months. The horses were
treated with phenylbutazone (1 mg/kg per os) every 12 hours
for the first three days postoperatively followed by the same
dose every 24 hours for another ten days. The follow-up exa-
minations, which included a complete lameness examination
and radiography of the surgical site, were carried out two,
four, six and 12 months after surgery. The same scoring system
was used for all evaluations pre- and postoperatively.
Outcome variables
The outcome was considered successful when the horse was
sound and able to be used normally in its intended athletic
discipline. In all other instances the outcome was considered
unsuccessful. A telephone inquiry was performed five to seven
years later.
Results
Signalment, results of clinical and radiographic examinations,
type of operation, amount of PTH1-34 in fibrin and outcome
are summarized in Tables 1 and 2.
M. A. Jackson et al.
Pferdeheilkunde 28 3
Fifteen horses with a total of 16 SCLs (one horse was affected
bilaterally) met the inclusion criteria. There were 10 warm-
blood horses, two arabian horses, one quarter horse, one
thoroughbred and one pinto horse. The mean age was 4.9
years (range, 2 months–10 years), and there were nine
mares, four geldings and two stallions. The median degree of
lameness was 3 (range, 1-5), and cyst density before treat-
ment was low in all the horses. Of the 16 SCLs, six were in
the medial condyle of the distal femur (one horse had bilate-
ral lesions), three in the distal metacarpus, three in the proxi-
mal sesamoid bones, two in the proximal phalanx, one in the
patella and one in the calcaneus. 
Radiographs showed communication between the joint and
SCL in ten cases and no communication in six (3 SCLs in the
proximal sesamoid bones, 2 in the proximal phalanx and 1 in
the patella). All the SCLs with joint communication were trea-
ted arthroscopically, whereas the SCLs without joint commu-
nication were treated via an extraarticular transosseous
approach. After curettage, 0.2 to 2.5 ml PTH1-34 in a fibrin
hydrogel was placed into the cavity using a volume that
depended on the size of the cyst (Table 1). 
The outcome of treatment was deemed successful in 11 of the
15 horses (73%), which included three SCLs located in the
medial condyle of the femur, three in the proximal sesamoid
bone, two in the distal metacarpus, one in the first phalanx,
one in the patella and one in the calcaneus. These horses
returned to their previous level of activity without recurrence
of lameness. In all cases with a successful outcome, radio-
graphic density of the cyst content was greater two to six
months postoperatively than preoperatively. At 12 months,
density of the defect was high in five cases (Figs. 2a and 2b),
moderate in another five (Figs. 3a and 3b) and mild in one
case. In nine cases the cystic lesion appeared smaller, in one
case the size was unchanged and in one it appeared larger.
None of the horses with a successful outcome developed
Fig.1a Case 6: Intraoperative view of the small opening of the
SCL to the medial femorotibial joint. b The cyst cavity after arthro-
scopic debridement. c The cyst has been filled with PTH1-34 in fibrin,
and clotting of the hydrogel occurred within 1 to 3 minutes.
a
c
b
Fig. 2a Case 1: Dorsopalmar radiographic view of an SCL after sur-
gical debridement in the distal third of the metacarpal bone. 
b Dorsopalmar radiographic view of the same SCL shown in (a) 12
months postoperatively, at which time a high cyst density was recorded.
a
b
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osteoarthrosis (OA) of the affected joint. Eight of the 11 hor-
ses with a successful outcome horses were ≤ 3 years old. 
In one horse (Case 1), the outcome was not considered suc-
cessful although the lameness improved after treatment. On
admission, the horse had a large SCL in the distal third meta-
carpal bone and OA of the adjacent metacarpophalangeal
joint. Twelve months after surgery, the cyst appeared healed
radiographically and had a high density. However, the horse
remained slightly lame (1/5) and could be used only for ple-
asure riding. Three horses with a total of four SCLs had an
unsuccessful outcome: Case 10 had an SCL in the medial
M. A. Jackson et al.
Pferdeheilkunde 28 5
femoral condyle and OA of the stifle joint. Previous treatment
consisted of several intraarticular injections of corticosteroids.
The horse was still lame after surgical treatment, and radio-
graphically the cyst remained unchanged in size and density.
Case 5 had an SCL in the distal aspect of the first phalanx
with an associated fissure fracture into the proximal inter-
phalangeal joint. Treatment consisted of internal fixation with
lag screws and debridement of the cyst. The horse developed
an implant infection, which required removal of the screws
after healing of the fissure. After 12 months, the cyst appea-
red larger radiographically and the horse had a grade 2/5
lameness. The third unsuccessful outcome occurred in Case
6, which had large SCLs in both distal femoral condyles, mild
OA of both stifle joints and a grade 3/5 right hind limb lame-
ness. Both cysts were treated during the same surgical inter-
vention. The horse showed initial improvement, but after 12
months still had a grade 3/5 right hind limb lameness, and
both SCLs were still clearly visible radiographically. Further-
more, the right femorotibial joint had signs of severe OA. The
owner elected to have the horse euthanased.
Discussion
The treatment of SCLs with PTH1-34 in a fibrin hydrogel admi-
nistered directly into the cyst after surgical curettage was con-
sidered successful in 11 of the 16 cysts (69%), with 11 of 15
horses (73%) becoming sound and returning to full work. The
use of PTH1-34 in a fibrin hydrogel for the treatment of SCLs
in the phalanges of three horses has previously been repor-
ted (Fürst et al. 2007, Kummerle et al. 2008). Here we des-
cribe a larger series of SCLs at different anatomic locations. 
Removal of the fibrous content and lining of the cyst is pro-
bably critical to ensure filling of the defect with bone tissue.
Residual cystic tissue is considered a contributing factor in
recurrence of the lesions because of the production of local
inflammatory mediators and matrix-degrading enzymes (von
Rechenberg et al. 2000). In our patients, debridement of the
cysts was achieved using straight and angled arthroscopic
curettes via an articular or extraarticular transosseus appro-
ach, depending on the location of the cyst. Although arthro-
scopy is the approach of choice for debridement of bone cysts
because it minimises the risk of postoperative complications
(Trotter und McIlwraith 1996), we had a better outcome in
patients that had undergone the extraarticular approach, pro-
bably because this caused less damage to the articular carti-
lage covering the cyst (Fürst et al. 2007). The disadvantage
of the extraarticular approach is that complete removal of the
cyst contents cannot be verified. 
It has been shown that when administered systemically, inter-
mittently and at lower dosages, PTH induces bone formation,
mostly in cancellous bone (Dempster et al. 1993). Local tre-
atment with PTH1-34 was therefore based on the hypothesis
that it induces new bone formation and accelerates bone
healing. To achieve this, PTH1-34 was incorporated into a
hydrogel with a natural base (fibrin), to produce a clot within
the cyst cavity, thus filling it. This was expected to facilitate fil-
ling of the cyst with bone tissue and prevent compression of
synovial fluid against the underlying compromised subchon-
dral bone during weight bearing, which may cause bone
resorption and enlargement of the cystic lesions (Trotter und
Fig. 3a Case 9: Caudocranial radiographic view of the right
femorotibial joint after surgical debridement of an SCL in the medi-
al femoral condyle. b The same radiographic view of the femoroti-
bial joint 12 months postoperatively showing moderate cyst density.
c The same radiographic view 18 months postoperatively showing
high cyst density.
a
b
c
McIlwraith 1996, Schmalzried et al. 1997). In human medi-
cine, hydrogels have been used as carriers of various growth
factors (Cascone et al. 1995).
Monitoring of healing of the SCLs was based on three varia-
bles (cyst density, approximate size of the cyst relative to the
limb, degree of lameness) in an attempt to maximise the reli-
ability of the findings of our study. The radiographic healing of
SCLs was based on cyst size and cyst density. In all cases with
a favourable outcome, there was reduction in the size of the
cyst and in 10 of 11 cases the density had increased by 12
months after surgery. Because none of the horses that became
sound underwent arthroscopy for a second time, healing of
the cartilage could not be assessed directly. However, becau-
se all cysts were near a weight-bearing surface of a joint and
the horses remained sound for several years after surgery, we
assumed that healing of cartilage was good. To assess healing
of subchondral cysts objectively, studies that include follow-up
arthroscopic examination of the affected joint and histological
examination of the tissue filling the defect as well as of the arti-
cular cartilage covering the defects are needed.
The most common location of the SCLs in the present study
was the medial femoral condyle, and five horses with a total
of six SCLs at that location were treated. Three horses less
than three years old became sound and two that were older
than three years and had radiographic signs of OA in the
affected joint before surgery remained lame. This was in
general agreement with the findings of Smith et al. (2005)
who found that horses older than three years have a worse
prognosis than younger horses with subchondral cysts. 
Three horses had an SCL in the distal metacarpus. Subchon-
dral cysts at these locations occur predominantly in the fore-
limbs, and are rarely bilateral (Nixon 1990). Two horses (3
and 5 years) returned to their intended use and one, which
was older then 3 years old and showed OA of the affected
joint, remained slightly lame. Similar results had been repor-
ted in an earlier study of 15 horses with SCLs of the third
metacarpal bone, where 80% became sound after surgery
(Hogan et al 1997). 
Three horses had SCLs in the proximal sesamoid bones. In
our patients, the cysts were debrided via a transosseus appro-
ach, and all three horses returned to their intended use. In
another study treatment of lesions at the axial aspect of the
sesamoid bone allowed four of five horses, all without evi-
dence of sepsis, to return to their previous use (Dabareiner et
al. 2001). However, in all these cases the cysts were debrided
arthroscopically. 
The lack of uniformity of our sample of patients with respect
to age, history of OA and related treatments and location and
size of the cysts is a limitation of the study. Subchondral cystic
lesions at different anatomic locations can be expected to dif-
fer with respect to clinical manifestation and response to tre-
atment, and this may explain, at least in part, the variation in
outcome. However, the presence of OA in the affected joint
and the age of the horse (older than 3 years) appeared to
influence negatively the healing of SCLs at different anatomic
locations. A transosseus approach, which helps to preserve
the articular cartilage over the cyst, appears to contribute to
a positive outcome. 
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Conclusions
Despite the limitations of the study, the following conclusions
can be drawn from our results. Regardless of anatomic loca-
tion, the filling of SCLs with PTH1-34-enriched fibrin hydrogel
after surgical debridement is a viable treatment that produces
clinical and radiographic outcomes comparable to those of
other therapeutic methods. The prognosis appears to be favou-
rable when an extraarticular transosseus approach is used,
when the affected joint does not present OA and when the
patients are not older than three years. Further studies using lar-
ger patient samples are needed to substantiate these findings.
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